04.01.2018
- Roche is planning to buy US group Ignyta for around $1.7 billion in an all-cash deal that will expand the Swiss group’s portfolio of cancer medicines. San Diego, California-based...
04.12.2017
- AstraZeneca and GI Therapeutics, a US clinical-stage oncology company, are collaborating to test a new combination therapy for lung cancer. The parties will evaluate AstraZeneca’s...
27.04.2017
- Bristol-Myers Squibb has announced another collaboration to use Opdivo in a combination cancer treatment, this time working with French biotech Transgene. The potential new therapy...
27.02.2017
- The US Food and Drug Administration (FDA) has accepted Swiss pharmaceutical major Novartis’ supplemental New Drug Application (sNDA) for filing and granted priority review for the...
17.09.2014
- Merck Serono, the biopharmaceutical division of Merck KGaA has decided to discontinue the clinical development program of its investigational MUC1 antigen-specific cancer...
